Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Purpose and Methods
Most patients who harbor a genetic mutation for hereditary breast cancer have not been identified, despite the availability of genetic testing. Developing an effective approach to the identification of high-risk individuals is the key to preventing and/or providing early diagnosis of cancer in this patient population. This educational review addresses these issues.
Results and Discussion
Using data available on the internet, and making assumptions regarding the types and results of genetic testing, we have estimated the number of mutation carriers in the country and the number who have been tested and identified as such. Overall, our ability to fund and more effectively manage carriers is weak. A technological solution is discussed.
- Scheuner, MT, Yoon, PW, Khoury, MJ (2004) Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and prevention. Am J Med Gen. 125C: pp. 50-65 CrossRef
- Crane, RM, Raymond, B (2003) Fulfilling the potential of clinical information systems. Permanente J. 7: pp. 62-67
- Ford, D, Easton, DF, Stratton, M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 62: pp. 676-689 CrossRef
- Wideroff, L, Vadaparampil, ST, Greene, MH (2005) Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 42: pp. 749-755 CrossRef
- Euhus, DM (2001) Understanding mathematical models for breast cancer risk assessment and counseling. Breast J. 7: pp. 224-232 CrossRef
- Parmigiani, G, Berry, DA, Aguilar, O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet. 62: pp. 145-158 CrossRef
- Antoniou, AC, Cunningham, AP, Peto, J (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 98: pp. 1457-1466 CrossRef
- Tyrer, J, Duffy, SW, Cuzick, J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 23: pp. 1111-1130 CrossRef
- Myriad Genetics Inc. Myriad for professionals. BRCA1 and BRCA2 prevalence tables. https://www.myriadpro.com/bracanalysis-prevalence-tables.
- Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol. 1996;14:1730–6.
- Roa, BB, Boyd, AA, Volcik, K, Richards, CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 14: pp. 185-187 CrossRef
- Palomaki, GE, McClain, MR, Steinort, K, Sifri, R, LoPresti, L, Haddow, JE (2006) Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women. Genet Med. 8: pp. 161-168 CrossRef
- Risch, HA, McLaughlin, JR, Cole, DEC (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 68: pp. 700-710 CrossRef
- US Census Bureau. http://factfinder.census.gov/servlet/QTTable?_bm=y&-geo_id=01000US&-qr_name=DEC_2000_SF1_U_QTP1&-ds_name=DEC_2000_SF1_U.
- Kurian, AW, Sigal, BM, Plevritis, SK (2009) Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 28: pp. 222-231 CrossRef
- American Cancer Society. Breast cancer overview. How many women get breast cancer? http://www.cancer.org/cancer/breastcancer/overviewguide/breast-cancer-overview-key-statistics.
- Myriad Genetics Inc annual reports (10-K) and quarterly reports (10-Q). http://www.getfilings.com/comp/k0000899923.html.
- Levy, DE, Garber, JE, Shields, AE (2009) Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization. J Gen Intern Med. 24: pp. 822-828 CrossRef
- Feero, WG, Bigley, MB, Brinner, KM (2008) New standards and enhanced utility for family health history information in the electronic health record: an update from the American health information community’s family health history multi-stakeholder workgroup. J Am Med Inform Assoc. 15: pp. 723-728 CrossRef
- Health level seven international. ANSI approved standards. http://www.hl7.org/implement/standards/ansiapproved.cfm.
- http://www.hughesriskapps.com. Accessed December 2010
- Claus, EB, Risch, N, Thompson, WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73: pp. 643-651 CrossRef
- Gail, MH, Brinton, LA, Byar, DP (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 81: pp. 1879-1886 CrossRef
- Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers
Annals of Surgical Oncology
Volume 19, Issue 6 , pp 1732-1737
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Division of Surgical Oncology, Department of Surgery, Avon Comprehensive Breast Evaluation Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- 2. Bermuda Cancer Genetics and Risk Assessment Clinic, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA